[PDF][PDF] Three neglected numbers in the CBC: The RDW, MPV, and NRBC count

JE May, MB Marques, VVB Reddy, R Gangaraju - Cleve Clin J Med, 2019 - ccjm.org
The complete blood cell count (CBC) is one of the most frequently ordered laboratory tests,
but some values included in the test may be overlooked. This brief review discusses 3 …

[HTML][HTML] Clinical factors and biomarkers predict outcome in patients with immune-mediated thrombotic thrombocytopenic purpura

…, CH Kim, NK Kocher, L Zheng, R Gangaraju… - …, 2019 - ncbi.nlm.nih.gov
Immune-mediated thrombotic thrombocytopenic purpura is characterized by severe
thrombocytopenia and microangiopathic hemolytic anemia. It is primarily caused by immunoglobin G …

Thrombotic, inflammatory, and HIF-regulated genes and thrombosis risk in polycythemia vera and essential thrombocythemia

R Gangaraju, J Song, SJ Kim, T Tashi… - Blood …, 2020 - ashpublications.org
Thrombosis is a major cause of morbidity and mortality in polycythemia vera (PV) and essential
thrombocythemia (ET). The pathophysiology of thrombosis in these disorders remains …

Race, rituximab, and relapse in TTP

…, HV Upreti, A Liu, MY Lim, R Gangaraju… - Blood, The Journal …, 2022 - ashpublications.org
Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is characterized by recurring
episodes of thrombotic microangiopathy, causing ischemic organ impairment. Black …

[HTML][HTML] Characteristics and outcomes of patients on concurrent direct oral anticoagulants and targeted anticancer therapies—TacDOAC registry: Communication from …

…, G Spectre, MY Lim, A Gahagan, R Gangaraju… - Journal of Thrombosis …, 2021 - Elsevier
Background Cancer patients are increasingly prescribed direct oral anticoagulants (DOACs)
and targeted anticancer therapies, but limited data are available on the outcomes during …

Longitudinal assessments of plasma ADAMTS13 biomarkers predict recurrence of immune thrombotic thrombocytopenic purpura

…, B Guillory, LA Williams, R Gangaraju… - Blood …, 2019 - ashpublications.org
Immune thrombotic thrombocytopenic purpura (iTTP) is primarily caused by immunoglobulin
G (IgG)–type autoantibodies that bind and inhibit plasma ADAMTS13 activity and/or …

Increased blood reactive oxygen species and hepcidin in obstructive sleep apnea precludes expected erythrocytosis

…, M Horvathova, R Gangaraju… - American Journal of …, 2023 - Wiley Online Library
Obstructive sleep apnea (OSA) causes intermittent hypoxia during sleep. Hypoxia predictably
initiates an increase in the blood hemoglobin concentration (Hb); yet in our analysis of 527 …

Biomarkers of bleeding and venous thromboembolism in patients with acute leukemia

…, S Bhatia, R Bhatia, N Mackman, R Gangaraju - Journal of Thrombosis …, 2024 - Elsevier
Background Coagulopathy and associated bleeding and deep vein thrombosis (DVT) are
major causes of morbidity and mortality in patients with acute leukemia. The underlying …

Regulation of erythropoiesis after normoxic return from chronic sustained and intermittent hypoxia

J Song, K Sundar, R Gangaraju… - Journal of Applied …, 2017 - journals.physiology.org
Hypoxia increases erythropoiesis mediated by hypoxia-inducible transcription factors (HIF),
which regulate erythropoietin transcription. Neocytolysis is a physiological mechanism that …

Late-occurring venous thromboembolism in allogeneic blood or marrow transplant survivors: a BMTSS-HiGHS2 risk model

R Gangaraju, Y Chen, L Hageman, J Wu… - Blood …, 2021 - ashpublications.org
Allogeneic blood or marrow transplant (BMT) recipients are at risk for venous
thromboembolism (VTE) because of high-intensity therapeutic exposures, comorbidities, and a …